ArticleScience translational medicine2022

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Mathieu Gigoux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.